Insider · CIK 0001279901
J Martin Carroll
director
Files at ESPR (Esperion Therapeutics, Inc.), CTLT (Catalent, Inc.). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 29, 2025 | ESPR Esperion Therapeutics, Inc. | AGrant or award Common Stock | +33,000 | $0.00 | $0 | 97,650 | Jun 2, 2025 |
| May 29, 2025 | ESPR Esperion Therapeutics, Inc. | AGrant or award Stock Option (right to buy)derivative | +44,000 | $0.00 | $0 | 44,000 | Jun 2, 2025 |
| Dec 18, 2024 | CTLT Catalent, Inc. | DDisposition to issuer Common Stock | -32,734 | - | - | 0 | Dec 18, 2024 |
| Oct 30, 2024 | CTLT Catalent, Inc. | AGrant or award Common Stock | +4,663 | $0.00 | $0 | 32,734 | Nov 1, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.